CAH
Cardinal Health, Inc. · Healthcare · Medical Distribution
TECHNeutralZACKSHold
R500#401 today
$228.30
-0.78% today · +3.91% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- CAH −0.78% on the last session vs SPY +0.74%: −1.5 pts of stock-specific move.
- Aftermath, big gain (Oct 1): After its 60 big gains in the past 5 years, CAH typically gained 0.5% over the next week (median) and was higher 60% of the time; half the outcomes fell between -1.2% and +3.2%. An ordinary week: +0.5%. Among S&P 500 stocks after big gains, that ranks #123 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 5
Before the open · in 32 days
EPS estimate
$2.94
$2.88 to $3.06 · 13 analysts
Revenue estimate
$66.6B
$65.1B to $67.3B
Track record
8/8 beats
last 8 reports · moved ±6.1% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 BMO | 4Q2026 | $2.42 | $2.60 | +$0.18 (+7.4%) beat | $63.7B | +1.3% +1.6 vs SPY | +2.5% | -0.6% |
| Apr 30, 2026 BMO | 3Q2026 | $2.79 | $3.17 | +$0.38 (+13.7%) beat | $60.9B | -4.9% -5.9 vs SPY | -3.7% | -5.6% |
| Feb 5, 2026 BMO | 2Q2026 | $2.37 | $2.63 | +$0.26 (+11.2%) beat | $65.6B | +9.8% +11.1 vs SPY | +4.9% | +8.4% |
| Oct 30, 2025 BMO | 1Q2026 | $2.17 | $2.55 | +$0.38 (+17.6%) beat | $64.0B | +15.4% +16.5 vs SPY | +10.3% | +19.6% |
| Aug 12, 2025 BMO | $2.03 | $2.08 | +$0.05 (+2.5%) beat | — | -7.2% -8.3 vs SPY | -10.6% | -5.0% | |
| May 1, 2025 BMO | $2.15 | $2.35 | +$0.20 (+9.3%) beat | — | +3.0% +2.3 vs SPY | -0.9% | +8.6% | |
| Jan 30, 2025 BMO | $1.76 | $1.93 | +$0.17 (+9.7%) beat | — | +0.4% -0.1 vs SPY | -0.5% | -0.2% | |
| Nov 1, 2024 BMO | $1.62 | $1.88 | +$0.26 (+16.0%) beat | — | +7.0% +6.6 vs SPY | +4.0% | +8.9% | |
| Aug 14, 2024 BMO | $1.73 | $1.84 | +$0.11 (+6.4%) beat | — | +3.7% +3.4 vs SPY | +6.3% | +6.1% | |
| May 2, 2024 BMO | $1.95 | $2.08 | +$0.13 (+6.7%) beat | — | +0.8% -0.1 vs SPY | -2.1% | -4.6% | |
| Feb 1, 2024 BMO | $1.60 | $1.82 | +$0.22 (+13.7%) beat | — | -3.8% -5.1 vs SPY | -4.8% | -3.2% | |
| Nov 3, 2023 BMO | $1.41 | $1.73 | +$0.32 (+22.7%) beat | — | +6.9% +6.0 vs SPY | +2.7% | +9.6% | |
| Aug 15, 2023 BMO | $1.48 | $1.55 | +$0.07 (+4.7%) beat | — | -2.6% -1.4 vs SPY | +1.4% | -6.5% | |
| May 4, 2023 BMO | $1.49 | $1.74 | +$0.25 (+16.8%) beat | — | -1.0% -0.3 vs SPY | -3.2% | +4.3% | |
| Feb 2, 2023 BMO | $1.14 | $1.32 | +$0.18 (+15.8%) beat | — | +0.7% -0.7 vs SPY | +2.0% | +5.5% | |
| Nov 4, 2022 BMO | $0.97 | $1.20 | +$0.23 (+23.7%) beat | — | +5.1% +3.6 vs SPY | +2.8% | +3.0% | |
| Aug 11, 2022 BMO | $1.18 | $1.05 | −$0.13 (−11.0%) miss | — | +5.2% +5.2 vs SPY | -3.4% | +10.1% | |
| May 5, 2022 BMO | $1.53 | $1.45 | −$0.08 (−5.2%) miss | — | -4.3% -0.8 vs SPY | -9.0% | -7.6% | |
| Feb 3, 2022 BMO | $1.23 | $1.27 | +$0.04 (+3.3%) beat | — | -0.3% +2.0 vs SPY | 0.0% | +4.6% | |
| Nov 9, 2021 BMO | $1.35 | $1.29 | −$0.06 (−4.4%) miss | — | -0.6% -0.3 vs SPY | +1.7% | +1.7% | |
| Aug 5, 2021 BMO | $1.20 | $0.77 | −$0.43 (−35.8%) miss | — | — | — | — | |
| May 6, 2021 BMO | $1.56 | $1.53 | −$0.03 (−1.9%) miss | — | — | — | — | |
| Feb 5, 2021 BMO | $1.45 | $1.74 | +$0.29 (+20.0%) beat | — | — | — | — | |
| Nov 5, 2020 BMO | $1.14 | $1.51 | +$0.37 (+32.5%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $2.94 (13) | $2.88 – $3.06 | +15% | +1.4% | ▲4 ▼3 | $66.6B | +4% |
| Next quarter · Dec 31, 2026 | $3.12 (13) | $3.01 – $3.37 | +19% | +4.6% | ▲7 ▼0 | $68.3B | +4% |
| Current year · Jun 30, 2027 | $12.57 (17) | $12.51 – $12.74 | +15% | +4.6% | ▲16 ▼0 | $265.9B | +5% |
| Next year · Jun 30, 2028 | $14.06 (17) | $13.15 – $14.90 | +12% | +4.0% | ▲12 ▼1 | $282.3B | +6% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.